Stock Information

Relmada Therapeutics Inc (RLMD)

Relmada Therapeutics Inc logo
Ticker Symbol: RLMD
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $676.54 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.1465
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -71.22%

Latest News

Key Financials

Financial data not available